Efficacy and Safety of the Combination of Valsartan Plus Amlodipine in Hypertensive Patients Not Adequately Responding to the Combination Therapy With Ramipril Plus Felodipine

• Status: Completed
• Trial end date: 2006-07-01

Summary

The purpose of this study is to evaluate the efficacy of valsartan plus amlodipine in hypertensive patients not responding to treatment with ACE inhibitor plus calcium channel blocker

• Phase: Phase 3

Details

• Lead Sponsor: Novartis
• Treatments: Amlodipine; Felodipine; Ramipril; Valsartan